Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

248
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
248
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

163
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
163
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

281
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
281
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

96
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
96
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

328
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
328

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Sex differences in plasma endocannabinoids and related lipids before and after single and repeated mTBI: an exploratory study of endolipid plasma biomarkers.

Frontiers in molecular neuroscience·2026
Same author

Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats.

Neuroscience bulletin·2026
Same author

Functional and microstructural biomarkers of repetitive mild head injury in a conscious momentum exchange mouse model.

Journal of neuroscience methods·2026
Same author

Filtering the noise: a cerebellar-centered framework for understanding and treating mental illness -a paradigm shift in psychiatry.

Frontiers in psychiatry·2026
Same author

Pharmacologic MRI Brain Imaging Studies of Serotonin 5-HT<sub>1</sub> Receptor Agonists in Awake Mice.

Pharmacology research & perspectives·2026
Same author

Beyond the toad's kiss: Mapping acute 5-MeO-DMT effects on brain connectivity across sex and dose using awake rat neuroimaging.

Neuropharmacology·2026

相关实验视频

Updated: Jun 5, 2025

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.4K

棕乙醇胺会导致大脑功能和脂质组的剂量依赖性变化.

Shreyas Balaji1, Taylor J Woodward2, Emily Richter2

  • 1Center for Translational Neuroimaging, Northeastern University, Boston, MA, United States.

Frontiers in neuroscience
|December 12, 2024
PubMed
概括

棕乙醇胺 (PEA) 改变大脑活动和大鼠的脂质概况. 这种常见的营养药物降低了大脑活动,但增加了功能连接,影响了许多大脑脂质.

关键词:
大胆的成像成像.小脑小脑是什么意思这是内分泌大麻素 (endocannabinoids) 的作用.功能连接性的功能连接性脂质组的类型是什么感觉运动皮层 (sensorimotor cortex) 是一个感觉运动皮层.

更多相关视频

Acyl-PEGyl Exchange Gel Shift Assay for Quantitative Determination of Palmitoylation of Brain Membrane Proteins
08:28

Acyl-PEGyl Exchange Gel Shift Assay for Quantitative Determination of Palmitoylation of Brain Membrane Proteins

Published on: March 29, 2020

6.6K
Metabolomic Analysis of Rat Brain by High Resolution Nuclear Magnetic Resonance Spectroscopy of Tissue Extracts
09:01

Metabolomic Analysis of Rat Brain by High Resolution Nuclear Magnetic Resonance Spectroscopy of Tissue Extracts

Published on: September 21, 2014

14.7K

相关实验视频

Last Updated: Jun 5, 2025

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.4K
Acyl-PEGyl Exchange Gel Shift Assay for Quantitative Determination of Palmitoylation of Brain Membrane Proteins
08:28

Acyl-PEGyl Exchange Gel Shift Assay for Quantitative Determination of Palmitoylation of Brain Membrane Proteins

Published on: March 29, 2020

6.6K
Metabolomic Analysis of Rat Brain by High Resolution Nuclear Magnetic Resonance Spectroscopy of Tissue Extracts
09:01

Metabolomic Analysis of Rat Brain by High Resolution Nuclear Magnetic Resonance Spectroscopy of Tissue Extracts

Published on: September 21, 2014

14.7K

科学领域:

  • 神经科学是一个神经科学.
  • 生物化学 生物化学
  • 营养学研究 营养学研究

背景情况:

  • 棕乙醇胺 (PEA) 是一种广泛使用的营养药.
  • 它对大脑功能和脂质化学的影响尚不清楚.
  • 需要新的研究方法来研究PEA的影响.

研究的目的:

  • 用MRI研究PEA对大脑功能的影响.
  • 分析PEA治疗后脂质化学的变化,特别是内源性脂质 (内脂质).
  • 建立对PEA对中枢神经系统 (CNS) 的影响的全面理解.

主要方法:

  • 醒着的老鼠被给予不同剂量的PEA (3,10或30毫克/公斤) 或载体.
  • 磁共振成像 (MRI) 用于测量血氧水平依赖 (BOLD) 信号和功能连接的变化.
  • 血和中枢神经系统中PEA和80多种内脂的水平使用广泛的脂管学量化.

主要成果:

  • 对于负面的BOLD信号,观察到一个反向的剂量反应,表明前额叶皮质,感觉运动皮质,基底质和thalamus等区域的大脑活动下降.
  • 在相同的大脑区域观察到功能连接的剂量依赖性增加.
  • 中枢神经系统中的PEA水平随着剂量增加而增加,而安纳米德和其他内分脂的水平显著下降.
  • 超过50%的检测到的内脂在至少一个中枢神经系统区域显示调节.

结论:

  • 在大鼠中,PEA治疗显著改变了大脑活动和功能连接.
  • EA显著影响中枢神经系统内内源性脂质特征.
  • 这些发现表明PEA驱动中枢神经系统活动和神经化学的实质性变化.